May 18, 2017

House subcommittee approves drug price measure with FDA bill

David Nather / Axios

A House panel quickly approved a bipartisan measure to speed the review of new generic drugs this morning, the first sign of congressional action this year to lower drug prices. The bill would require the FDA to conduct faster reviews of new generic drugs in markets where there's no competition, which would help address situations like the huge price increases for EpiPens. It was added to a larger measure that reauthorizes the user fees that help fund the FDA.

Why it matters: Republicans and Democrats don't agree on most ways to bring down drug prices, and Democrats on the committee have been pushing for a hearing on the issue. But encouraging more competition among generic drugs is fairly non-controversial solution that unites both parties.

Go deeper

WHO won't call coronavirus a pandemic as cases spread

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens.

The World Health Organization will not yet call the coronavirus a pandemic, claiming that needs across affected countries are too varied and the classification would increase fear, per a briefing Monday.

The big picture: As South Korea and Italy stepped up emergency measures in efforts to thwart the spread of the virus, WHO expressed concern about infections with no clear link to China. COVID-19 has killed at least 2,620 people and infected almost 80,000 others, with all but 27 deaths occurring in mainland China.

Go deeperArrowUpdated 20 mins ago - Health

The global scramble to contain the coronavirus

Taking precaution, in the Philippines. Photo: Ezra Acayan/Getty Images

The coronavirus is spreading quickly in cities nowhere near Wuhan, China, and the window to prevent a global pandemic is narrowing.

Zoom in: Here's a look at what comes with a coronavirus outbreak in communities outside China that have been hardest hit so far.

Go deeperArrow38 mins ago - World